EUVIMEDEUVIMED entdecken
Crossref

Organoid bioprinting for vascularized tumor assembloids

Zhenzhen Zhou, Yuan Pang, Zhendong Liao, Chang Zhou, Meiling Fu, Changru Liu, Yuting Guo, Kamto Yang, Jianyu He, Botao Gao, Marie Shinohara, Yasuyuki Sakai und 1 weitere

Trends in Biotechnology · 2026-11 · 44 (11) · 3305-3333

DOI: 10.1016/j.tibtech.2026.04.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Biotechnology, 2026-11. Verfasst von Zhenzhen Zhou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Biomanufacturing and Rapid Forming Technology Key Laboratory of Beijing Institute for Intelligent Healthcare, Key Laboratory for Advanced Materials P…. Hauptthemen laut MEDLINE: Organoids, Bioprinting, Neoplasms. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Natural Science Foundation of Chongqing Municipality, Beijing Science and Technology Planning Project, Guangdong Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The complexity and heterogeneity of the tumor microenvironment significantly influence cancer progression and therapeutic outcomes, highlighting the need for physiologically relevant in vitro models. In this study, we present vascularized tumor assembloids (VTASs) constructed via organoid bioprinting using a cell aggregate-rich living gel composed of endothelialized hepatic tumor aggregates and suspended endothelial cells. These VTASs recapitulate dense, volumetric, and hierarchical tissue architectures with functional vasculature and hepatic characteristics. Drug screening revealed reduced apoptosis and delayed intracellular drug accumulation in VTASs with dense microvasculature compared with cell-based or sparsely vascularized models, demonstrating differential responses to cisplatin, sorafenib, combination therapy, and doxorubicin. Co-culture with immune cells captured monocyte-endothelial interactions under inflammatory stimulation. Upon in vivo implantation, VTASs formed perfused tumorlike structures that recapitulated key histological and functional features of human cancer. Thus, VTASs provide a scalable and physiologically relevant platform for studying tumor biology, immune interactions, and high-throughput anticancer drug evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsBioprintingNeoplasmsHumansAnimalsTumor MicroenvironmentAntineoplastic AgentsMiceCoculture TechniquesNeovascularization, Pathologic

Stichwörter der Autor:innen

assembloidcell aggregatesliving gelsmicrovascular networkorganoid bioprintingtumor microenvironment

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Biomanufacturing and Rapid Forming Technology Key Laboratory of Beijing Institute for Intelligent Healthcare, Key Laboratory for Advanced Materials Processing Technology, Ministry of Education, Biomanufacturing Center,…
  • National Engineering Research Center for Healthcare Devices, Guangdong Key Lab of Medical Electronic Instruments and Materials, Institute of Biological and Medical Engineering, Guangdong Academy of Sciences, Guangzhou 5…
  • Institute of Industrial Science, University of Tokyo, Tokyo 153-8505, Japan.
  • Department of Chemical System Engineering, Graduate School of Engineering, University of Tokyo, Tokyo 113-8656, Japan.

Förderung

  • Natural Science Foundation of Chongqing Municipality
  • Beijing Science and Technology Planning Project
  • Guangdong Academy of Sciences
  • Tsinghua University
  • Beijing Nova Program
  • National Key Research and Development Program of China
  • Higher Education Discipline Innovation Project
  • National Natural Science Foundation of China

Zitieren

APA

Zhou, Z., Pang, Y., Liao, Z., Zhou, C., Fu, M., Liu, C., Guo, Y., Yang, K., He, J., Gao, B., Shinohara, M., Sakai, Y., & Sun, W. (2026). Organoid bioprinting for vascularized tumor assembloids. Trends in Biotechnology, 44(11), 3305-3333. https://doi.org/10.1016/j.tibtech.2026.04.009

Vancouver

Zhou Z, Pang Y, Liao Z, Zhou C, Fu M, Liu C, et al. Organoid bioprinting for vascularized tumor assembloids. Trends in Biotechnology. 2026;44(11):3305-3333. doi:10.1016/j.tibtech.2026.04.009

BibTeX
@article{Zhou2026,
  author = {Zhou, Zhenzhen and Pang, Yuan and Liao, Zhendong and Zhou, Chang and Fu, Meiling and Liu, Changru and Guo, Yuting and Yang, Kamto and He, Jianyu and Gao, Botao and Shinohara, Marie and Sakai, Yasuyuki and Sun, Wei},
  title = {Organoid bioprinting for vascularized tumor assembloids},
  journal = {Trends in Biotechnology},
  year = {2026},
  volume = {44},
  number = {11},
  pages = {3305--3333},
  doi = {10.1016/j.tibtech.2026.04.009}
}
Kostenlos starten →